Rank-sum tests indicated no significant relationships between CD302 expression level and T stage (P = 0.097), N stage (P = 0.409), overall TNM stage (P = 0.114), or differentiation (P = 0.357), whereas a significant difference was observed for tumor diameter (P = 0.043). This evidence concerns the gene CD302 and neoplasm.